Cassava Sciences, Inc.
SAVA
$2.73
$0.155.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 37.92% | -25.11% | 147.96% | -26.61% | -488.86% |
| Gross Profit | -37.92% | 25.11% | -147.96% | 26.61% | 488.86% |
| SG&A Expenses | -123.83% | 228.51% | 1,113.34% | -15.73% | 20.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.67% | 13.79% | 113.37% | -24.81% | 8.37% |
| Operating Income | 13.67% | -13.79% | -113.37% | 24.81% | -8.37% |
| Income Before Tax | -31.92% | -8.94% | 123.34% | 203.18% | -9.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.92% | -8.94% | 123.34% | 203.18% | -9.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.92% | -8.94% | 123.34% | 203.18% | -9.33% |
| EBIT | 13.67% | -13.79% | -113.37% | 24.81% | -8.37% |
| EBITDA | 13.46% | -14.47% | -115.25% | 24.88% | -8.69% |
| EPS Basic | -15.71% | 4.63% | 121.11% | 200.15% | -5.67% |
| Normalized Basic EPS | 25.42% | 0.86% | 121.12% | 200.17% | -5.15% |
| EPS Diluted | -14.60% | 4.63% | 120.60% | 26.90% | -6.69% |
| Normalized Diluted EPS | 25.42% | 0.86% | 121.12% | 197.66% | -5.15% |
| Average Basic Shares Outstanding | 14.01% | 14.22% | 10.55% | 3.02% | 3.47% |
| Average Diluted Shares Outstanding | 14.01% | 14.22% | 10.55% | 5.66% | 3.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
